Griffyn Robotech Will Manufacture and Supply Mass Ventilators to the Government of India


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Griffyn Robotech Will Manufacture and Supply Mass Ventilators to the Government of India
Due to shortage of ventilators, caretakers and medical staff uses bag valve mask devices to manually ventilate patients for prolonged periods of time leading to mortality and morbidity. To address this, Griffyn Robotech has developed affordable AI specilized ventilation devices to treat patients

With COVID-19 cases multiplying at an alarming rate, Griffyn Robotech, an Artificial Intelligence (AI) innovations company headquartered in Pune, has announced manufacturing and mass supply of ventilators to support the Government of India in the fight against COVID-19 virus. The lethal coronavirus is known to affect the respiratory system of the patient who is required to be put on a ventilator, a machine that adds pressure to pump oxygen into the bloodstream and take out carbon dioxide from the lungs of the patient.

According to estimates by Government of India, the country needs 50,000 ventilators over the next two months. While the government has fast-tracked imports, the bulk of this shortfall has to be met by domestic manufacturers to fulfill the supply and demand gap. In this hour of crisis, Griffyn Robotech, with its other partners, scheduled for a Webex meeting to discuss the impact of the pandemic and initiatives that can be implemented to help the nation. The company was inspired by MIT ventilator design and created its own design using 3D printing technology to bring to the market 'Shwaas' an Ambu-bag based ventilator in the fight against COVID-19.

Speaking about the AI enabled ventilator, Mr. Amit Mahajan, Founder & CEO of Griffyn Robotech Pvt. Ltd., said, "Ventilators and other respiratory aids are critical devices in the fight against COVID-19, and to this end we are working together with our partners to ensure manufacturing and steady supply of ventilators in India. As a socially responsible and caring brand, we are committed to serving society in every way possible."

"Further to this effect, we will be creating an open API and extensible platform that can be leveraged for extended features to be rapidly introduced in next few weeks. We are also planning to collaborate with other start-ups for creating addons to the platform. We are all proud 'Desh Bhakts' and are glad to contribute with our skills so that we all win together the fight against the pandemic."

He further adds, "We will be applying to be one of the many suppliers to the government to manufacture ventilators on a large scale that can save millions of lives across India and globally to combat the COVID-19 pandemic. This will ensure we have enough ventilators and are prepared to tackle the coronavirus outbreak."

Due to shortage of ventilators, caretakers and medical staff uses bag valve mask devices to manually ventilate patients for prolonged periods of time leading to mortality and morbidity. To address this, Griffyn Robotech has developed affordable AI specilized ventilation devices to treat patients with respiratory illnesses during emergencies and mass casualties, as an alternative for prolonged manual ventilation.

As per recent reports, India which only spends about 1 per cent of its gross domestic product on healthcare, has allocated fewer than 20,000 ventilators for the treatment of COVID-19 patients. The public health research organisation, based in Washington and New Delhi, estimates India will need as many as 1m ventilators to address the peak of coronavirus cases.

Tags : #Griffynrobotech #Massventilators #AI

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Immuneel Therapeutics and THSTI Announce Strategic Partnership to Advance CAR-T Cell Therapy and Lentiviral Vector Manufacturing July 28, 2026
Differential Diagnosis of Acute Abdomen: Differentiating Surgical Emergencies from Gastrointestinal MimicsJuly 28, 2026
Management of Rheumatic Heart Disease in Developing Nations: Secondary Prophylaxis and Valve InterventionsJuly 28, 2026
Hormonal Imbalance in Women: Understanding the Causes, Recognising the Symptoms, and Finding the Right TreatmentJuly 28, 2026
Why Regular Health Screening Matters: A Complete Guide for IndiansJuly 28, 2026
Galderma introduces Sculptra® in India, ushering in a new era of regenerative aestheticsJuly 27, 2026
Artificial Intelligence in Diagnostic Imaging: Enhancing Radiologist Precision and Reducing Human ErrorJuly 27, 2026
Transitioning from Acute Care to Urgent Care Centers: Optimizing Healthcare Facility InfrastructureJuly 27, 2026
Ahead of World Head & Neck Cancer Day, HNCII Launches “Delay is the Real Killer” Cancer Awareness CampaignJuly 25, 2026
Ahead of World Head & Neck Cancer Day, HNCII Launches “Delay is the Real Killer” Cancer Awareness CampaignJuly 25, 2026
Menopause Symptoms Explained: What Every Indian Woman Should KnowJuly 25, 2026
Sleep Deprivation and Its Hidden Impact on Your Health: What Every Indian Should KnowJuly 25, 2026
Air Pollution and Health Effects: What Every Indian Must KnowJuly 25, 2026
NABH Accreditation Explained: What It Means for Indian Hospitals and PatientsJuly 25, 2026
Hypertension in Young Indians: Causes and Early InterventionJuly 24, 2026
How Stress Damages Your Heart: The Mind-Body ConnectionJuly 24, 2026
Living with Arthritis in India: Pain Management and Lifestyle TipsJuly 23, 2026
Iron Deficiency vs B12 Deficiency: Spotting the Difference in IndiansJuly 23, 2026
The ePlane Company and Apollo Hospitals Join Forces to Bring India's Golden Hour Within ReachJuly 23, 2026
Importance of Women's Health Screening: A Comprehensive Guide to Preventive CareJuly 23, 2026